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Introduction
The myelin sheath is critical for the rapid and efficient conduc-
tion of nerve impulses in the vertebrate nervous system (Richie, 
1984). Myelin forms in stages. In the developing peripheral ner-
vous system (PNS), Schwann cells first segregate off large di-
ameter axons into a 1:1 relationship, a process termed radial 
sorting (Feltri and Wrabetz, 2005; Sherman and Brophy, 2005). 
Subsequently, Schwann cells circumferentially extend a mem-
brane process around the axon to form the myelin sheath (Bunge 
et al., 1989). In contrast, small-caliber axons remain ensheathed 
within separate pockets of a nonmyelinating Schwann cell, 
forming a Remak bundle (Griffin and Thompson, 2008).
The signals that direct Schwann cells to initiate myelina-
tion and regulate the thickness of the myelin sheath are incom-
pletely understood (Pereira et al., 2012; Salzer, 2012). Two 
broad sources of extrinsic signals have been implicated in these 
events: axonal factors and components of the ECM. In particu-
lar, the type III isoform of Neuregulin1 on the axon surface and 
laminin-2 in the basal lamina are required for Schwann cells to 
segregate and myelinate axons properly (Bunge et al., 1986; 
Nave and Salzer, 2006). In addition to these major extrinsic sig-
nals, several additional signals have also recently been impli-
cated in Schwann cell development (Glenn and Talbot, 2013).
These signals activate distinct receptors and signaling path-
ways. Neuregulin1 binds to the erbB2 and erbB3 coreceptors on 
The PI 3-kinase (PI 3-K) signaling pathway is essen-tial for Schwann cell myelination. Here we have characterized PI 3-K effectors activated during 
myelination by probing myelinating cultures and devel-
oping nerves with an antibody that recognizes phos-
phorylated substrates for this pathway. We identified a 
discrete number of phospho-proteins including the S6 
ribosomal protein (S6rp), which is down-regulated at the 
onset of myelination, and N-myc downstream-regulated 
gene-1 (NDRG1), which is up-regulated strikingly with 
myelination. We show that type III Neuregulin1 on the 
axon is the primary activator of S6rp, an effector of 
mTORC1. In contrast, laminin-2 in the extracellular 
matrix (ECM), signaling through the 64 integrin and Sgk1 
(serum and glucocorticoid-induced kinase 1), drives phos-
phorylation of NDRG1 in the Cajal bands of the abax-
onal compartment. Unexpectedly, mice deficient in 64 
integrin signaling or Sgk1 exhibit hypermyelination dur-
ing development. These results identify functionally and 
spatially distinct PI 3-K pathways: an early, pro-myelinating 
pathway driven by axonal Neuregulin1 and a later-
acting, laminin–integrin-dependent pathway that nega-
tively regulates myelination.
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signaling from a pro-myelinating, Neuregulin1-dependent path-
way to a laminin–integrin–Sgk1 pathway that negatively regu-
lates PNS myelination.
Results
PI 3-K signaling substrates are distinctly 
regulated with myelination
To monitor the activity of the PI 3-K pathway during myelina-
tion, we used an antibody raised against the phosphorylated sub-
strate recognition motif for a subset of AGC kinases (i.e., Akt, 
Sgk, p90 RSK, and p70 S6K; Zhang et al., 2002). We stained my-
elinating co-cultures of sensory neurons and Schwann cells with 
this antibody to localize putative PI 3-K substrates (Fig. 1). Every 
myelinating Schwann cell, identified by their expression of myelin 
basic protein (MBP), was robustly stained by the phospho-substrate 
(p-Sub) antibody along the length of the sheath. Phospho-substrates 
were also enriched in the Schmidt-Lanterman incisures (SLI; 
Fig. 1 C) and in the paranodes (Fig. 1 D), suggesting these regions 
are also foci of PI 3-K activity.
As all Schwann cells in these cultures were associated with 
axons but only myelinating Schwann cells were strongly stained, 
axonal contact is not sufficient to up-regulate these phospho- 
substrates. A subset of premyelinating Schwann cells that had 
elongated along the axon but expressed little if any MBP were 
also positively stained (Fig. 1 A, arrowheads in magnified insets). 
Premyelinating Schwann cells were identified by their expression 
of Oct-6/POU3F1, a transcription factor transiently up-regulated 
just before myelination (Fig. 1 B; Bermingham et al., 1996; 
Jaegle et al., 2003). Quantification of one set of cultures revealed 
that 10% (n = 154) of the premyelinating (POU3F1+/MBP) 
cells were also stained by the p-Sub antibody. These results indi-
cate that one or more phospho-substrates are up-regulated just 
before formation of compact myelin.
To further characterize the temporal expression of phospho-
substrates, we used the p-Sub antibody to probe lysates from 
co-cultures that had myelinated for different times. These blots 
revealed a discrete number of bands (Fig. 2 A), most of which 
were up-regulated with myelination, indicated by increased 
myelin protein zero (P0) expression; this up-regulation is con-
sistent with the increase in staining with the same antibody at 
the onset of myelination (Fig. 1 A). The most prominently up-
regulated band is a doublet of 45 kD. In contrast, at least two 
phospho-proteins of 30 and 250 kD were down-regulated 
with myelination. Expression of these bands was also detected 
at lower levels in neuron-only and Schwann cell–only cultures, 
respectively (unpublished data).
These results suggest expression of these, and other phospho- 
proteins in Schwann cells, neurons, or both were altered as a con-
sequence of axon–glial interactions. To determine if prolonged 
axon–Schwann cell interactions were sufficient to modulate their 
expression or myelination was required, we co-cultured Schwann 
cells and neurons together for 35 d in the presence or absence 
of ascorbate, which is required for myelination (Eldridge et al., 
1987). We blotted the lysates with the p-Sub antibody, using p45 
and p30 as representative substrates that are up-regulated and 
down-regulated, respectively (Fig. 2 B). Only the myelinated 
the inner (i.e., the adaxonal) Schwann cell membrane (Canoll 
et al., 1996; Vartanian et al., 1997; Michailov et al., 2004). 
Neuregulin1-bound erbB2/3 activates PI 3-kinase (PI 3-K), 
among other pathways implicated in Schwann cell myelination 
(Maurel and Salzer, 2000; Kao et al., 2009; Newbern et al., 
2011). In contrast, laminin receptors such as integrins and dystro-
glycan are present on the outer (i.e., the abaxonal) membrane 
(Einheber et al., 1993; Feltri et al., 1994; Saito et al., 2003). The 
61 integrin has been shown to signal through Rac, focal adhe-
sion kinase (FAK), and potentially integrin-linked kinase (ILK), 
in the radial sorting of axons before myelination (Feltri et al., 
2002; Grove et al., 2007; Nodari et al., 2007; Pereira et al., 2009). 
As myelination proceeds, the 64 integrin and dystroglycan 
predominate and may function to stabilize myelin (Nodari et al., 
2008). 64 can activate several downstream pathways including 
PI 3-K (Giancotti, 2007); the precise role of this integrin in medi-
ating signaling in the PNS has not been examined.
In this study, we have focused on the PI 3-K pathway, 
which generates the signaling intermediates phosphatidylinosi-
tol biphosphate (PI-3,4-P2) and triphosphate (PI-3,4,5-P3) at 
the membrane (Cantley, 2002). PI 3-K activity is opposed by 
the lipid phosphatase and tensin homologue (PTEN), which hy-
drolyzes these phosphatidylinositols (Maehama and Dixon, 
1998). The importance of this pathway in myelination is under-
scored by studies in which conditional ablation of PTEN in my-
elinating glia was shown to result in hypermyelination (Goebbels 
et al., 2010). Conversely, pharmacological inhibition PI 3-K sig-
naling blocks myelination initiation (Maurel and Salzer, 2000).
Although PI 3-K is critical for myelination, its temporal 
activation and its various downstream effectors are incompletely 
characterized. Many signaling molecules in the PI 3-K pathway 
are activated by phosphatidylinositol-dependent kinase1 (PDK1), 
which binds PI-3,4-P2 and PI-3,4,5-P3 in the plasma membrane 
(Alessi et al., 1997a). Two well-described examples are Akt and 
Sgk (serum and glucocorticoid-induced kinase; Mora et al., 
2004). These closely related serine–threonine kinase families 
both have three isoforms and share a substrate recognition motif 
(RXRXX*S/T) with each other and with the p70 and p90 ribo-
somal S6 kinases (Alessi et al., 1996; Kobayashi et al., 1999). 
Generation of antibodies against this sequence has facilitated 
investigations of the spatial and temporal expression of PI 3-K 
effectors (Kane et al., 2002; Kamimura et al., 2008).
Here we use this phospho-substrate antibody to character-
ize PI 3-K pathways and their effectors during myelination. Our 
findings support a model in which Neuregulin1 on the axon 
drives activation of Akt and thereby the mammalian target of 
rapamycin (mTOR) pathway in Schwann cells at the onset of 
myelination. Subsequently, laminin in the ECM activates Sgk1 
via the 64 integrin, resulting in the phosphorylation of 
NDRG1 (N-myc downstream-regulated gene1), a Schwann cell 
phospho-protein critical for myelin stability (Kalaydjieva et al., 
2000; Okuda et al., 2004). Phospho-NDRG1 is highly ex-
pressed in the Cajal bands of the abaxonal compartment, impli-
cating these cytoplasmic channels as focal sites of integrin 
signaling. Unexpectedly, loss of either 4 integrin signaling or 
of Sgk1 enhances myelination during development. These 
results demonstrate a spatiotemporal progression of PI 3-K 
1221PI 3-kinase pathways differentially regulate myelination • Heller et al.
phosphorylated N-myc downstream–regulated gene 1 (NDRG1), 
a protein of similar size that is phosphorylated at several sites, 
including Ser330 and Thr346/Thr356/Thr366 (3xThr; Murray 
et al., 2004). We used the p-Sub antibody to blot lysates from 
stretcher nerves, which express minimal levels of truncated 
NDRG1 and no full-length protein (King et al., 2011). p45 was 
undetectable in the stretcher nerve lysates (Fig. 3 A), confirming 
that this band corresponds to NDRG1. We also stained myelina-
ting organotypic cultures prepared from wild-type and stretcher 
cultures exhibited the characteristic up-regulation of p45 and 
down-regulation of p30, suggesting that myelination regulates 
either their expression and/or their phosphorylation.
Identification of phospho-substrate 
proteins
To identify the p30 and p45 proteins, we took a candidate approach 
based on previous reports using the p-Sub antibody (Kane et al., 
2002). We first examined whether p45 might correspond to 
Figure 1. Phospho-substrates are up-regulated with myelination. (A) Myelinating co-cultures of rat sensory neurons and Schwann cells stained for 
MBP (red), p-Sub (green), and laminin (white); boxed areas are shown at higher magnification below at 1.5×. Myelinating Schwann cells (inset, arrow) 
are selectively stained with the phospho-substrate antibody (p-Sub). Some Schwann cells that have elongated but are not yet expressing MBP at sig-
nificant levels are stained with the p-Sub antibody (arrowheads). Bar, 75 µm. (B) Staining of myelinating co-cultures for p-Sub (green), POU3F1 (red), 
and MBP (blue) is shown. A subset of premyelinating POU3F1-expressing Schwann cells coexpress phospho-substrates (arrow). All MBP-expressing 
Schwann cells, which are POU3F1-negative, coexpress phospho-substrates (arrowheads). Bar, 10 µm. (C) Myelinating co-cultures stained with p-Sub 
(green), Mupp1 (red), and MBP (blue) indicate that phospho-substrates are enriched in the SLI. Bar, 5 µm. (D) Myelinating co-cultures stained with p-Sub 
(green), Caspr1 (red), and MBP (blue) indicate that phospho-substrates are sometimes enriched in the distal glial paranode (arrow), extending into the 
juxtaparanode (arrowhead). Bar, 5 µm.
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To elucidate where in the Schwann cell these signaling 
events were localized, we stained myelinating co-cultures for 
p-Akt, p-S6rp, and p-NDRG1. The localization of p-Akt (S473) 
depended on the maturity of the myelin sheath (Fig. 4 A); it was 
initially localized along the length of the myelinating Schwann cell 
but concentrated at the paranodes as the sheath matured. Thus, 
at five days in myelinating media, premyelinating and nascent 
myelinating Schwann cells expressed p-Akt along the length of 
their processes. As myelination proceeded, p-Akt was localized 
to the paranodes of mature myelin sheaths, identified by expres-
sion of Caspr; p-Akt also was similarly localized in neonatal 
sciatic nerves (Fig. S1 C). This staining was specific, as it was 
lost when co-cultures were pretreated for 24 h with the PI 3-K 
inhibitor LY294002.
Staining of p-S6rp only partially overlapped with p-Akt. 
p-S6rp was most robustly expressed in nonmyelinating and 
23% (n = 172) of premyelinating (POU3F1+/MBP) Schwann 
cells (Fig. 4 B). Only a few MBP+ Schwann cells (3%) ex-
pressed p-S6rp, and these were weakly stained (an example is 
marked by an asterisk in Fig. 4 B). These data are consistent 
with Western blotting results showing that S6rp is down- 
regulated with myelination (Fig. 2 B and Fig. 3 C). The p-S6rp 
staining was present in the soma of premyelinating Schwann 
cells and in their processes that extended along and ensheathed 
neurites; no staining within neurites was detected.
Total and phosphorylated NDRG1 appeared to be enriched 
in the abaxon of myelinating Schwann cells (Fig. 4 C). Similar to 
p-Sub, we observed an occasional enrichment to the paranode in 
which p-Akt is localized. Taken together, these data suggest that 
p-Akt and p-S6rp are expressed at an early stage of axon–Schwann 
cell contact, whereas NDRG1 is downstream of a distinct path-
way that is activated later in the abaxonal compartment.
To determine whether p-NDRG1 is indeed concentrated 
in the abaxonal compartment, we performed immunoelectron 
microscopy of myelinating co-cultures (Fig. S2, A and B). For 
immuno-EM, the numbers of gold particles in the abaxonal, 
mice with the p-Sub and three NDRG1-specific antibodies 
(Berger et al., 2004; Sommer et al., 2013). We found that total 
and phospho-specific NDRG1 antibodies only stained the wild-
type but not the stretcher cultures, indicating these antibodies 
are specific for NDRG1 (Fig. S1 A). In contrast, although stain-
ing of stretcher cultures with the p-Sub staining antibody was 
reduced, notably in the abaxon (Fig. S1 B), it was not abolished. 
These latter data show that NDRG1 is a major but not the only 
phosphorylated substrate in myelinating Schwann cells detected 
by the p-Sub antibody (Fig. 1 A).
We considered whether p30 is the S6 ribosomal protein 
(S6rp), a protein of similar molecular weight that is phosphory-
lated by S6 kinase and is downstream of Akt and mTOR sig-
naling (Magnuson et al., 2012). We treated nonmyelinating 
co-cultures with inhibitors of PI 3-K (LY294002), mTor/TORC1 
(rapamycin), and S6 kinase (PF4708671) for 18 h. Each inhibi-
tor abolished p30 phosphorylation (Fig. 3 B), confirming that 
this band is p-S6rp.
Expression and localization of phospho-
substrate proteins during myelination
We next examined the time course of Akt, S6rp, and NDRG1 
phosphorylation during sciatic nerve development by Western 
blotting (Fig. 3 C). Based on Akt phosphorylation, PI 3-K is most 
active early in development and decreases as myelination pro-
ceeds. Phosphorylation of both Akt sites (i.e., T308, the PDK1 
phosphorylation site, and S473, the TORC2 phosphorylation site; 
Alessi et al., 1997b; Sarbassov et al., 2005) is down-regulated 
with myelination. Similarly, S6rp is highly phosphorylated early 
and then down-regulated. The decrease in p-Akt and p-S6rp lev-
els may also result from the decrease in total Akt and S6rp levels 
that accompanies myelination. In contrast, phospho- and total 
NDRG1 levels are robustly up-regulated with myelination. These 
data suggest that an early-acting PI 3-K pathway drives Akt and 
S6rp signaling and a late-acting PI 3-K pathway regulates NDRG1 
phosphorylation, potentially independent of Akt.
Figure 2. Phospho-substrates are differen-
tially expressed during myelination. (A) Time 
course of the expression of phospho-substrates 
in myelinating co-cultures. Western blot analy-
sis of lysates prepared from co-cultures begin-
ning on day 0, when myelinating media was 
added, through day 21. Six major bands were 
detected that either increased or decreased 
as myelination proceeded. The p-Sub reactive 
bands are in red, -actin in green; P0 myelin 
protein expression is also shown. (B) Co-cultures 
of Schwann cells and sensory neurons were 
maintained for 35 d under nonmyelinating 
(NM) or myelinating (Myel.) conditions. The in-
crease in p45 and decrease in p30 observed 
in the time course shown in A only occur under 
myelinating conditions.
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(dy3k/dy3k) mice (blots shown in Fig. 6 A, quantification in Fig. 6 B). 
Nerves were analyzed at P10 when both NDRG1 and S6rp are 
normally robustly phosphorylated (Fig. 3 C). Mice haploinsuf-
ficient for type III Neuregulin1, which are known to be hypo-
myelinated (Michailov et al., 2004; Taveggia et al., 2005), had 
reduced levels of p-Akt (T308) and of p-S6rp but normal lev-
els of p-NDRG1. Similarly, p-S6rp is virtually undetectable in 
Schwann cells co-cultured under myelinating conditions with 
Neuregulin1 type III–null sensory neurons relative to their 
wild-type counterparts (Fig. S2 C). In contrast, p-NDRG1 was 
decreased dramatically in the dy3k/dy3k mice, in addition to a 
modest reduction in p-S6rp levels. Thus, S6rp phosphorylation 
is driven by Neuregulin1 and potentially by laminin, whereas 
NDRG1 phosphorylation is primarily laminin dependent.
NDRG1 phosphorylation is dependent on 
laminin receptors
These data indicate laminin is necessary for NDRG1 phosphory-
lation. To determine whether it is also sufficient, we applied 
laminin, with or without the LY inhibitor, for 30 min to serum-
starved cultures of pure Schwann cells or co-cultures of Schwann 
cells and sensory neurons (Fig. S3, A and B). Addition of lam-
inin resulted in robust NDRG1 phosphorylation only in Schwann 
cells co-cultured with neurons; there was no increase when lam-
inin was added to Schwann cells cultured alone. The application 
of soluble Neuregulin1 type III also up-regulated NDRG1 phos-
phorylation in nonmyelinating cultures, suggesting that signal-
ing is not compartmentalized before the formation of the abaxon 
and adaxon (Fig. S3 C). These data indicate that the signaling 
pathway(s) that drive NDRG1 phosphorylation downstream of 
laminin require axonal contact.
We next examined the role of Schwann cell laminin recep-
tors in transducing the phosphorylation signal, focusing on the 
61 and 64 integrins. Both integrins are expressed on the 
abaxonal membrane of Schwann cells; 64 expression is axon 
adaxonal, and compact myelin compartments were determined 
in a blinded manner. Localization in each compartment was rep-
resented as a percentage of total particles counted in all three 
compartments. Myelin-associated glycoprotein and MBP served 
as controls for proteins expressed in the adaxon and in compact 
myelin, respectively. Analysis revealed more gold particles for 
phosphorylated NDRG1 (S330) in the abaxon than in compact 
myelin or the adaxon, supporting an abaxonal localization.
We also stained adult teased nerve fibers for total and 
p-NDRG1 (3xThr) and with antibodies to Necl–4, a marker of 
the Schwann cell periaxonal membrane and clefts (Maurel 
et al., 2007; Spiegel et al., 2007) and to -dystroglycan (-DG), 
a laminin receptor exclusive to the abaxonal Schwann cell mem-
brane. Total NDRG1 was present in the adaxonal compartment, 
in the SLI, and in the abaxonal compartment (Fig. 5 A). In con-
trast, p-NDRG1 was present only in the outer aspect of the SLI 
and in the abaxonal compartment (Fig. 5 B); no adaxonal stain-
ing was observed. By imaging the surface of the nerve fibers 
(Fig. 5, C and D), we determined that both total and p-NDRG1 
are enriched in the Cajal bands (i.e., the cytoplasmic channels 
that form between -DG–positive appositions in the abaxonal 
compartment). Taken together, these data indicate that total and 
phosphorylated NDRG1 are enriched in the Cajal bands and 
clefts. Although total NDRG1 is present in the adaxonal com-
partment, as previously reported (Berger et al., 2004), it is not 
phosphorylated in this site.
S6rp is a substrate of Neuregulin1 type III 
signaling; NDRG1 is a substrate of  
laminin signaling
The distinct spatial and temporal patterns of p-S6rp and NDRG1 
phosphorylation suggest that they are activated by different 
signals. We therefore compared substrate phosphorylation of 
NDRG1 and S6rp in two in vivo mouse models: (1) Neuregulin1 
type III haploinsufficient mice (Nrg1+/), and (2) laminin-2–null 
Figure 3. S6rp and NDRG1 correspond to 
the 30- and 45-kD phospho-substrate bands. 
(A) Western blots of wild-type and stretcher 
sciatic nerve lysates were probed with anti-
NDRG1 and p-Sub antibodies; -actin serves 
as a loading control. NDRG1 and the p45-kD 
p-Sub doublet are not detected in the stretcher 
nerve lysates. (B) Western blots of lysates from 
nonmyelinating co-cultures were treated with 
50 nM rapamycin, 20 µM LY294002, or 40 µM 
PF-4708671 for 18 h and then probed with 
p-Sub, p-S6rp, and total S6rp antibodies. 
p-S6rp and p30 are not detectable in co- 
cultures treated with rapamycin, LY294002, or 
PF-4708671. (C) Expression of phospho- and 
total Akt, NDRG1, and S6rp in developing 
rat sciatic nerves. Lysates of postnatal sciatic 
nerves were probed on Western blots with 
the indicated antibodies. Both total and phos-
phorylated NDRG1 are up-regulated in paral-
lel with compact myelin proteins P0 and MBP. 
S6rp and Akt are maximally expressed and 
phosphorylated early, then down-regulated as 
myelination proceeds.
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Figure 4. Localization of p-S6rp, p-NDRG1, and p-Akt in myelinating co-cultures. (A) Co-cultures maintained in myelinating media for 5 or 14 d were 
stained for p-Akt (green), Caspr (red), and MBP (blue). In 5-d co-cultures (top row), Schwann cells just before myelinating express p-Akt (S473) along their 
length; Caspr staining of axons is diffuse and MBP is not yet expressed. In 14-d co-cultures (bottom two rows), p-Akt staining varied depending on the matu-
rity of the myelin segments. In a thinly myelinated segment with a single paranode (bracket), p-Akt was prominent along the Schwann cells, in more mature 
segments with two hemi-paranodes (arrows) or surrounding a mature node (arrowheads) staining was concentrated in the paranodal and juxtaparanodal 
regions. Addition of the LY inhibitor before fixation abolished p-Akt staining. Bar, 20 µm. (B) Myelinating co-cultures were stained for p-S6rp (green), 
POU3F1 (red), and MBP (blue). p-S6rp was maximally expressed in the cytoplasm and along the processes of a premyelinating Schwann cell expressing 
POU3F1 (arrows) and at lower levels in myelinated Schwann cells (one is marked by an asterisk). Bar, 20 µm. Inset (far right panel) is at 2×. (C) Myelinating 
co-cultures stained for phospho- (3xThr, S330) and total NDRG1 (all green), MBP (blue), and Caspr (red). Myelinating Schwann cells express phospho- and 
total NDRG1 (green) along the outside of the myelin sheath and in some paranodes (insets, 3× magnification). Bar, 20 µm.
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Figure 5. NDRG1 is enriched in the Cajal bands of the abaxonal compartment. (A) A teased adult rat sciatic nerve fiber stained for total NDRG1 (green) 
and Necl-4 (red) is shown. Total NDRG1 is present in the abaxon (green arrow), adaxon (yellow arrow), and throughout the length of the SLI (white brack-
ets); Necl-4 is present in the adaxonal membrane and the incisures. Inset is rotated and shown at 3×. Bar, 20 µm. (B) Teased adult rat sciatic nerve fiber 
stained for phospho-NDRG1 (green) and Necl-4 (red) is shown. p-NDRG1 is expressed in the abaxon (green arrow) but not the adaxon (red arrow) and 
only the outer portion of the SLI (white brackets). Necl-4 is expressed throughout the entire incisures. A Cajal band is present in the center of the fiber (white 
asterisks). Inset is rotated and shown at 3×. Bar, 20 µm. (C and D) Teased P45 mouse sciatic nerve fibers stained for (C) total or (D) p-NDRG1 (green) 
and -dystroglycan (red); SLI are labeled with white arrowheads. Both total and p-NDRG1 are enriched in the Cajal bands and excluded from the -DG 
stained appositions. Bar, 20 µm.
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NDRG1 kinase, although recent data suggest that Akt may also 
play a role (Burchfield et al., 2004; Murray et al., 2004; Sommer 
et al., 2013). We therefore examined NDRG1 phosphorylation 
in P10 and adult knockout nerves from Sgk1- and Sgk3-null 
animals; these two Sgk isoforms are the sole isoforms expressed 
in Schwann cells based upon RT-PCR analysis (Fig. 8 A). We 
found a major reduction in NDRG1 phosphorylation at the 3xThr 
sites in the Sgk1 knockout nerves at P10 and at all sites (S330, 
3xThr) in the adult (Fig. 8 B and Fig. S4 C). Sgk3 knockout 
nerves also showed a reduction of phosphorylation at the 3xThr 
sites. These data provide strong support for an important but not 
an exclusive role of Sgk1 in NDRG1 phosphorylation.
Because phosphorylation at S330 was not reduced in ei-
ther Sgk-null mice at P10, we examined NDRG1 phosphoryla-
tion in the Akt1, 2, and 3 knockout nerves (Fig. S4 D). Loss of 
Akt1, but not of Akt2 or 3, decreased p-S330 but not p-3xThr. 
Therefore, both Akt1 and Sgk1 contribute to NDRG1 phosphory-
lation during development, whereas Sgk1 and Sgk3 are the major 
NDRG1 kinases in the adult.
Loss of 4 integrin signaling and Sgk1 
enhance myelination during development
These studies suggest that Sgk1 is an important regulator of 
NDRG1 phosphorylation in myelinating Schwann cells. Al-
though Sgk1-null mice develop normally and do not exhibit any 
overt neurological phenotype, the role of Sgk1 in myelination 
has not been specifically examined (Wulff et al., 2002; Fejes-
Tóth et al., 2008). To address its function in myelination di-
rectly, we analyzed P10 sciatic nerve from Sgk1-null, heterozygous, 
and wild-type siblings by EM (Fig. 9). Sgk1-null nerves ap-
peared normal, but on close inspection exhibited thicker myelin 
sheaths on average than their wild-type littermates (Fig. 9 A). 
This was confirmed by the reduced g-ratios in the knockout 
mice, in which there is a dose-dependent effect of Sgk1 as 
heterozygotes had g-ratios intermediate between wild-type 
contact dependent and up-regulated with myelination in a pat-
tern similar to that of NDRG1 phosphorylation; 1 persists dur-
ing myelination but is maximally expressed before myelination 
and by Schwann cells cultured alone (Einheber et al., 1993; 
Feltri et al., 1994). Floxed alleles of the 1 and 4 integrin sub-
units, and of -DG were conditionally ablated in Schwann cells 
beginning at E15 using the P0 Cre driver line (Feltri et al., 
1999). Nerves from the P0 Cre driver line served as a control.
We analyzed NDRG1 phosphorylation in lysates of P10 
nerves deficient in each of these laminin receptors (Fig. 7 A and 
Fig. S4 A). Nerves deficient in -DG exhibited a modest reduc-
tion of NDRG1 phosphorylation at both sites. A more signifi-
cant reduction was observed in the 1 and 4 integrin conditional 
nulls but only at Ser330. This latter result suggests that there 
may be compensatory mechanisms in the integrin nulls that res-
cue downstream signaling of the p-3xThr site. To test this possi-
bility, we examined a loss-of-function knock-in mouse model in 
which 4 integrin is missing its canonical signaling domain; 
this mutant is expressed at physiological levels, heterodimerizes 
with the 6 subunit, and binds to laminin properly (Nikolopoulos 
et al., 2004). NDRG1 phosphorylation was significantly reduced 
at both sites in the 4 integrin signaling mutant. These data sug-
gest that there are cooperative effects of laminin receptors in 
promoting NDRG1 phosphorylation, with a key role of 4 inte-
grin in transducing the laminin signal to NDRG1. Importantly, 
phosphorylation of S6rp is not significantly reduced in the 4 
integrin–signaling mutant (Fig. 7 B and Fig. S4 B) indicating its 
phosphorylation is distinctly regulated from NDRG1 and is not 
primarily downstream of matrix–integrin interactions.
Akt1 and Sgk1 contribute to  
NDRG1 phosphorylation
To determine the kinases downstream of 4 integrin, and other 
laminin receptors, that phosphorylate NDRG1 we took a can-
didate approach. Sgk1 has been proposed to be the primary 
Figure 6. Neuregulin1 and laminin-2 differentially regulate S6rp and NDRG1 phosphorylation. (A) Lysates of P10 nerve from Neuregulin1 type III haplo-
insufficient or 2-laminin–null (dy3k/dy3k) mice were blotted for total and phosphorylated Akt, S6rp, and NDRG1. Whereas p-Akt is reduced in both nerves, 
phospho-NDRG1 is markedly reduced only in the 2-laminin–null mice. (B) Quantification of the phosphoprotein levels in neuregulin and laminin mutant 
nerves are shown normalized to total protein in each case. Mean ± SEM; *, P < 0.05; ***, P < 0.001 by two-tailed Student’s t test; n ≥ 3.
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Discussion
Schwann cell myelination depends on a discrete number of ex-
trinsic signals originating from the axon and the ECM (Pereira 
et al., 2012; Salzer, 2012; Glenn and Talbot, 2013). These sig-
nals, in turn, activate a complex set of intracellular pathways. 
Elucidating the effectors of these pathways, and determining 
the sites where they act, will be essential to an understanding of 
how these ligands and pathways cooperate to promote myelin 
assembly. Here, we have characterized further the PI 3-K path-
way during myelination. Our studies indicate that PI 3-K is 
transiently activated by Neuregulin1 at the onset of myelina-
tion, driving the Akt/mTOR pathway; subsequently, PI 3-K is 
activated by laminin as the sheath matures, activating Sgk1 and 
inhibiting myelination (Fig. 10). Our data further suggests these 
pathways are spatially segregated. These findings are consid-
ered further below.
Neuregulin1 signaling is the main activator 
of mTOR at the onset of myelination
We previously demonstrated that type III Neuregulin1 is the key 
signal on the axon that activates PI 3-K, which in turn is essen-
tial for myelination (Maurel and Salzer, 2000; Taveggia et al., 
2005). Here we demonstrate that type III Neuregulin1 on the 
axon is also the major driver of TORC1 activation, based on 
p-S6rp levels. During initial interactions, p-Akt is present along 
the length of the elongated, premyelinating Schwann cells 
(Fig. 4 A) in direct apposition to the axon and thus Neuregulin1. 
Similarly, p-S6rp is present in the ensheathing processes of pre-
myelinating Schwann cells (Fig. 4 B). p-S6rp levels are acti-
vated in concert with p-Akt and well before the peak of laminin 
signaling indicated by NDRG1 phosphorylation (Fig. 3 C). Fi-
nally, genetically reducing or ablating Neuregulin1 in vivo and 
in vitro resulted in reduced activation of p-Akt and p-S6rp (Fig. 6 
and Fig. S2 C).
There may also be a modest, supplemental role of laminin–
integrin signaling in the activation of PI 3-K/Akt/mTOR in my-
elinating Schwann cells. p-S6rp levels are somewhat reduced in 
laminin-deficient mice at P10 (Fig. 6). This may be a direct effect 
and knockout nerves (Fig. 9 E). This effect is most evident in 
small- and medium-caliber axons (Fig. 9 F).
Additional abnormalities observed in the Sgk1 nulls in-
cluded more complete sorting of larger-caliber axons com-
pared with controls. Thus, there were 15 unsorted axons larger 
than 1.1 µm in diameter among the 50 fields of wild-type 
nerves examined (Fig. 9 B); all axons of this size were sorted 
in 50 fields of Sgk1 nulls. There were also twice as many 
smaller-caliber axons (i.e., less than 0.9 µm in diameter) that 
were myelinated in the Sgk1 nulls relative to the wild types, 
and these tended to be hypermyelinated (P > 0.05). Finally, we 
also observed examples of polyaxonal myelination, i.e., mul-
tiple small-caliber axons that were myelinated in common by 
a single Schwann cell, in the Sgk1 nulls (Fig. 9 C); none were 
observed in the wild-type or heterozygote mice. No abnormal-
ities of Remak fibers were observed in the nulls, indicating the 
defects are specific to myelinated fibers. Taken together, these 
findings indicate that radial sorting is accelerated and myelin 
sheath thickness increased in Sgk1-null nerve at P10, impli-
cating Sgk1 as a negative regulator of myelination during 
early development.
Because Sgk1 signals downstream of 64, we also exam-
ined myelination in the 4-signaling mutant mice. These mice 
also demonstrated modest hypermyelination (Fig. 9 D; quantified 
in Fig. S5 A), which was most evident in fibers of medium diam-
eter (1.5–2.5 µm).
Taken together, these results unexpectedly implicate in-
tegrin signaling from the matrix via PI 3-K/Sgk1 as an inhibi-
tor of myelination. Several proteins have been identified as 
negative regulators of PI 3-K/Akt signaling (i.e., DLG1, PTEN, 
and REDD1; Cotter et al., 2010; Noseda et al., 2013). We there-
fore examined whether their expression was altered in Sgk1-
null nerves (Fig. S5 B). We found that none of these molecules 
were significantly altered. Whereas REDD1 levels were mod-
estly reduced, mTOR activity (indicated by p-S6rp levels), its 
negatively regulated effector, was not consistently increased. 
These results suggest that the mechanism(s) by which 4 inte-
grin and Sgk1 down-regulate myelination may involve other 
signaling pathways.
Figure 7. 4 integrin is a key laminin re-
ceptor upstream of NDRG1 phosphorylation.  
(A) Lysates from P10 nerves deficient in various 
laminin receptors were probed for alterations 
in NDRG1 phosphorylation at the p-S330 and 
p-3xThr sites. p-NDRG1 levels are normal-
ized to total NDRG1 for each quantification. 
Conditional ablation of the 1 (n = 3) and 4 
(n = 4) integrin subunit causes a defect on S330 
phosphorylation but not p-3xThr. The signal-
ing-defective 4 mutant (4/; n = 7) exhibits 
a marked reduction of phosphorylation at both 
the S330 and 3xThr sites. The DG-null has 
a small but significant defect at both S330 
and 3xThr (n = 5). Mean ± SEM; *, P ≤ 0.05; 
**, P < 0.01; ***, P < 0.001 by two-tailed 
t test. (B) P10 4-signaling mutant nerves have 
normal levels of S6rp phosphorylation. Quanti-
fications were normalized to total S6rp protein 
levels. Mean ± SEM; n = 4; P > 0.05 by two-
tailed t test.
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2000) and of ablating Neuregulin1 and erbB2 in the adult 
(Atanasoski et al., 2006; Fricker et al., 2009). Thus, although 
activation of PI 3-K by Neuregulin1 is critical for the initial 
events of myelination, it is dispensable for myelin maintenance. 
The decline in p-Akt activity along the internode may be mul-
tifactorial. One mechanism is the recruitment of PTEN to the 
adaxonal compartment, where it interacts with and is likely 
stabilized by DLG1 (Ozçelik et al., 2010; Sandoval et al., 2013). 
In addition, we have found that total Akt levels are substantially 
down-regulated during myelination (Fig. 3 C), likely further 
limiting signaling.
The reduction of p-Akt along the internode is accompa-
nied by its enrichment within the paranodes in vitro and in vivo 
during active myelination (Fig. 3 C, Fig. 4 A, and Fig. S1 A). 
Enrichment of p-Akt in the paranodes was also observed in 
PTEN-conditional mice, which exhibit markedly elevated PI 
3-K activity (Goebbels et al., 2010), and is consistent with lo-
calization of phospho-substrates at this site (Fig. 1 D). Akt may 
be activated in the paranodes as the result of converging signals 
from adaxonal erbB receptors and abaxonal laminin receptors. 
In addition, the autotypic adherens junctions, which form be-
tween the paranodal loops themselves, may be another source 
of PI 3-K activity (Fannon et al., 1995; Rivard, 2009). Enrich-
ment of phospho-substrates in the SLI (Fig. 1 C and Fig. 5) fur-
ther supports the clefts as a locus of PI 3-K signaling.
Phospho-NDRG1 localization implicates 
Cajal bands as sites of laminin and 64 
integrin signaling
Both total and p-NDRG1 are dramatically up-regulated with 
myelination (Fig. 3 C), consistent with a previous report (Berger 
et al., 2004). These authors also reported that NDRG1 is ex-
pressed throughout the Schwann cell cytoplasm. Here, we show 
both total and p-NDRG1 are strikingly enriched in the Cajal 
bands, providing compelling evidence that NDRG1 is concen-
trated abaxonally (Fig. 5 B). The Cajal bands are anastomosing 
of laminin or, alternatively may reflect its role in promoting 
Schwann cell ensheathment of axons and thereby erbB recep-
tor phosphorylation and PI 3-K/Akt/mTOR activation (Yu et al., 
2005; Berti et al., 2011). The former possibility is suggested 
by the slight reduction of p-S6rp in the 4 integrin–signaling 
mutant at P10 (Fig. 7 B), although this did not reach statistical 
significance. In addition, p-S6rp is detected at low levels in the 
soma of some myelinating Schwann cells (Fig. 4 B) in culture 
and in the adult mouse (Sherman et al., 2012), consistent with 
direct activation in the abaxonal compartment downstream of 
laminin. Taken together, these data indicate that Neuregulin1 on the 
axon is the major regulator of S6rp phosphorylation and TORC1 
activity during development; however, once myelination is com-
plete, laminin signaling may contribute to low-level activation.
mTOR has a key role during PNS myelination based on 
conditional knockouts of mTOR in embryonic Schwann cells, 
which exhibit thin, short myelin sheaths (Sherman et al., 2012). 
These results further implicate the Neuregulin1/PI 3-K/Akt/
mTOR pathway in the radial and longitudinal expansion of the 
myelin sheath. They also suggest that the hypomyelination ob-
served in mice haploinsufficient for Neuregulin1 (Michailov 
et al., 2004; Taveggia et al., 2005) likely results, in part, from 
reduced mTOR activity. The precise role(s) of mTOR during 
myelination remains to be established but may reflect its key 
role in regulating protein translation (Laplante and Sabatini, 
2013), potentially including translation of proteins required for 
myelination. Indeed, the expression of p-S6rp in ensheathing 
processes (Fig. 4 B) is appropriately localized to regulate local 
translation at the onset of myelin biosynthesis.
Spatiotemporal changes in PI 3-kinase 
signaling during myelination
As myelination proceeds, PI 3-K activity progressively de-
creases (Fig. 3 C), including along the internode (Fig. 4 A). 
This reduction is consistent with the limited effects of inhibiting 
PI 3-K after myelination is established (Maurel and Salzer, 
Figure 8. Sgk isoforms phosphorylate NDRG1. (A) RT-PCR of first-strand cDNA obtained from pure sensory neurons, Schwann cells, and kidney (control) 
using Sgk isoform-specific primers demonstrates Sgk1 and Sgk3 are expressed by Schwann cells. (B) Quantification of Western blots analyzing phosphory-
lation at the p-S330 and 3xThr sites of NDRG1 in P10 and adult (P60) sciatic nerves from Sgk1- or Sgk3-specific knockouts. Sgk1 loss of function reduces 
NDRG1 phosphorylation at the 3xThr site at P10 and at both sites in the adult. Sgk3 loss of function slightly increases p-S330 and decreases 3xThr in the 
adult. p-NDRG1 was normalized to total NDRG1, which was similar across phenotypes, for the quantification. Mean fold change relative to wild type ± 
SEM, n ≥ 4. *, P < 0.05; ***, P < 0.001 by two-tailed Student’s t test.
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Figure 9. Sgk1-null mice are hypermyelinated during development. (A) Representative electron microscopic fields of P10 nerves from wild-type and 
Sgk1/ mice are shown, demonstrating modest hypermyelination of some fibers in the null nerve. Bars, 5 µm. (B) At P10, large-caliber axons (asterisk) are 
still occasionally ensheathed in the Remak bundles of wild-type but not Sgk1 knockout nerves (not depicted). Bar, 1 µm. (C) An example of multiple small 
axons (asterisks) communally myelinated by a single Schwann cell from the Sgk1-null mice is shown. Bar, 1 µm. (D) Representative electron microscopic 
fields of P10 nerves from wild-type and 4-signaling mutant mice are shown, demonstrating modest hypermyelination of some fibers in the mutant nerve. 
Bars, 5 µm. (E) Quantification of the g-ratios in P10 nerves from wild-type (884 axons scored), Sgk1+/ (942 axons scored), and Sgk1/ (796 axons 
scored) mice. Loss of Sgk1 results in a modest hypermyelination that is dose dependent. Mean g-ratios are shown ± SEM; **, P < 0.01; ****, P < 0.0001 
by ANOVA. (F) Quantification of the g-ratios in P10 nerves from wild type, Sgk1+/, and Sgk1/ binned by axon caliber. Mean g-ratios are shown ± 
SEM; ***, P < 0.001; ****, P < 0.0001 by ANOVA and Tukey’s multiple comparisons test.
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in vivo and in vitro (Einheber et al., 1993; Feltri et al., 1994) with 
a time course and localization similar to that shown here for 
p-NDRG1. Further, phosphorylation of NDRG1, but not of S6rp, is 
markedly reduced in the 4 signaling mutant (Fig. 7). This trun-
cated mutant lacks a cytoplasmic domain required for the activa-
tion of a number of downstream pathways, including PI 3-K (Guo 
et al., 2006; Giancotti, 2007). Unexpectedly, reduction of NDRG1 
phosphorylation was more robust in the 4 signaling mutant than 
in the 4 knockout, as both the 3xThr and S330 sites were af-
fected in the former. This may reflect compensation in 4 knock-
outs, including up-regulation of the 1 integrin subunit (Spinardi 
et al., 1995; Nodari et al., 2008), which does not occur in the 
knock-in signaling mutant. Alternatively, the signaling mutant 
may function in a dominant-negative manner.
Sgk1 is downstream of laminin-4  
integrin signaling
We have used NDRG1 to monitor signaling downstream of 
laminin and laminin receptors. Sgk1 has been thought to be the 
primary NDRG1 kinase; indeed, NDRG1 is widely used as a 
readout of Sgk1 activity (Pearce et al., 2011; Thomanetz et al., 
2013). Consistent with this, NDRG1 phosphorylation is sub-
stantially reduced at both S330 and 3xThr in the Sgk1-null adult 
nerve (Fig. 8). But in the P10 nerve, Akt1 and Sgk1 both con-
tribute to NDRG1 phosphorylation acting on the S330 and 
3xThr sites, respectively (Fig. 8 and Fig. S5). These results 
indicate that Sgk1 is not the exclusive NDRG1 kinase and are 
cytoplasmic channels interposed between -DG–positive appo-
sitions that form between the outer Schwann cell membrane and 
the compact myelin sheath (Sherman and Brophy, 2005). Al-
though their precise function is not known, the Cajal bands are 
thought to provide a conduit for the centrifugal transport of 
proteins and RNA from the perinuclear region (Gould and 
Mattingly, 1990; Court et al., 2004).
This abaxonal localization is consistent with the depen-
dence of NDRG1 phosphorylation on laminin-2 and laminin re-
ceptor signaling. Both 1 and 4 integrins contribute to the PI 
3-K signaling upstream of NDRG1 as phosphorylation at the 
S330 site was markedly reduced in the respective knockouts 
(Fig. 7 and Fig. S4). Of note, 1 integrin is enriched in the outer 
Schwann cell membrane immediately overlying Cajal bands 
and 4 is present throughout the abaxonal membrane, including 
overlying the Cajal bands (Nodari et al., 2008; Court et al., 
2011). 1 may activate PI 3-K by activating focal adhesion ki-
nase and/or integrin-linked kinase (Reiske et al., 1999; Troussard 
et al., 2003), both of which play key roles in myelination (Grove 
et al., 2007; Pereira et al., 2009). However, the reduced phos-
phorylation of NDRG1 in the 1 knockout mice may be indi-
rect—the result of aberrant myelination in these mice (Feltri 
et al., 2002), which would be expected to impair expression of 
both NDRG1 and 4 integrin.
We consider 4 the likely signaling receptor upstream of 
NDRG1. 4, which is obligately associated with 6, is dramati-
cally up-regulated in Schwann cells at the onset of myelination 
Figure 10. Schematic of PI 3-K pathways activated during myelination. Schematic of the proposed transition in PI 3-K during myelination. In premyelinat-
ing Schwann cells (left), Neuregulin1 drives myelination by activating TORC1 through erbB-dependent PI 3-K/Akt activation. In myelinating Schwann cells 
(right), pro-myelinating signals are opposed by laminin signaling via 64 integrin and Sgk1. This signaling is localized to the Cajal bands of the abaxon; 
among the targets of Sgk1 phosphorylation is NDRG1, a protein required for long-term myelin maintenance.
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Laminin-4 integrin-Sgk1 signaling 
negatively regulates myelination
As laminin signals have long been considered to be pro- 
myelinating (Bunge et al., 1986), we were surprised that loss 
of 4 signaling and Sgk1 enhanced myelination at P10. This 
was most pronounced in the case of the Sgk1 mutants, which 
exhibit a dose-dependent increase in myelin thickness, more 
advanced segregation of large-caliber axons, and examples 
of multiple small axons myelinated en masse by single Schwann 
cells (Fig. 9). The 4 signaling mutant also exhibited evi-
dence of hypermyelination, most evident in mid-sized fibers 
(Fig. 9 D and Fig. S5 A). Of note, some of the abnormalities 
in the developing Sgk1-null nerve partially phenocopy lam-
inin and dystroglycan complex mutants. Although the most 
striking defects of the 2 and 4 laminin knockouts are a 
failure of radial sorting and of myelin initiation, these nerves 
also display examples of hypermyelinated fibers and polyax-
onal myelination, respectively (Bradley and Jenkison, 1973; 
Wallquist et al., 2005). Hypermyelination of axons and poly-
axonal myelination have also been observed in human dys-
trophic nerves (Di Muzio et al., 2003) and mice with conditional 
ablation of dystroglycan or periaxin (Gillespie et al., 2000; 
Saito et al., 2003). Thus, laminin and laminin-dependent path-
ways appear to have multiple functions during myelination—an 
initial, essential role in axon wrapping in which Rac1 signaling 
has been implicated (Nodari et al., 2007) and, based on these 
studies, a subsequent role as a negative regulator of myelination 
via Sgk1 activation.
The mechanism(s) responsible for hypermyelination in 
the Sgk1 nulls is not yet known but is of significant interest. 
Whether reduced phosphorylation of NDRG1 contributes, or 
acts in concert with, other as yet to be identified Sgk1 targets to 
mediate these effects are important questions for future study. 
Identification of these Sgk1 effectors may provide novel thera-
peutic targets to enhance myelin repair.
Materials and methods
Neuron, Schwann cell, and myelinating co-cultures
Primary and myelinating co-cultures were established as described previ-
ously (Maurel et al., 2007). In brief, dorsal root ganglia (DRG) were re-
moved from E16 rats or E14 mice and dissociated for 45 min with 0.25% 
(vol/vol) trypsin (Life Technologies) or applied directly to pre-coated 12-mm 
coverslips (Karl Hecht GmbH) for explant cultures. Unless otherwise noted, 
coverslips were coated with collagen (Trevigen, Inc.). Cultures were main-
tained in Nunclon 4-well tissue culture plates (Thermo Fisher Scientific) at 
37°C and 5% CO2. Pure neuron cultures were obtained by cycling the cul-
tures with C-media in the presence or absence of 10 µM fluorodeoxyuri-
dine (Sigma-Aldrich) for 2 wk; C-media is based in MEM (Life Technologies) 
and contains 10% fetal calf serum (FCS; Life Technologies), 0.4% (wt/vol) 
glucose (Sigma-Aldrich), 50 µg/µL 2.5S NGF (AbD Serotec), and 2 mM 
l-glutamine (Life Technologies). Organotypic cultures were maintained in 
C-media for two feedings before the use of C+C media (i.e., C-media with 
0.05 mg/ml ascorbate; Sigma-Aldrich) to induce myelination. Neuron cul-
tures were seeded with purified, neonatal sciatic nerve Schwann cells (1.5 × 
105 cells per coverslip; Brockes et al., 1979) to obtain a co-culture; such 
cultures were maintained in C-media for nonmyelinating or C+C for my-
elinating conditions. Schwann cell cultures were maintained in Schwann 
cell media (SC-media) that contained MEM, 10 µM l-glutamine, 10% FCS, 
4 µM forskolin (LC Labs), and 5 ng/ml glial growth factor (R&D Systems). 
Neurons from neuregulin1 type III mice were obtained from E13.5 timed 
pregnancies, genotyped as described previously (Taveggia et al., 2005), 
and maintained as described above.
consistent with a recent report that altered Akt or Sgk expres-
sion results in compensatory changes in NDRG1 phosphoryla-
tion (Sommer et al., 2013). Taken together, these studies indicate 
that Akt1 and Sgk1 are expressed and phosphorylate NDRG1 in 
the developing peripheral nerve, whereas Sgk1 is the predomi-
nant NDRG1 kinase in the adult.
Two related questions concern the function of NDRG1 
in myelination and the consequences of phosphorylation on its 
function. In addition to Schwann cells, NDRG1 is widely ex-
pressed by many types of cells. It has been extensively studied 
as a metastasis suppressor that promotes differentiation and 
antagonizes cell cycle progression (Melotte et al., 2010; Bae 
et al., 2013). However, the most important phenotype exhib-
ited by NDRG1 nulls is a demyelinating neuropathy (Okuda 
et al., 2004; King et al., 2011), i.e., Charcot Marie Tooth 4D 
(Kalaydjieva et al., 2000). The requirement for NDRG1 in 
myelin maintenance and its localization to the Cajal bands 
raises the possibility these structures may also contribute to 
myelin maintenance. In the future, it will be of interest to de-
termine whether loss of NDRG1 affects transport, signaling, 
and/or maintenance of the Cajal bands.
Our results suggest that NDRG1 phosphorylation may be 
dispensable for its function in myelination. In the Sgk1-null and 
4 signaling mutant nerves, NDRG1 phosphorylation was mark-
edly reduced (Figs. 7 and 8) without any clear effect on myelin 
stability at early ages and without an overt clinical phenotype. 
Analysis of myelin structure in the adult mutant mice will be 
useful to address this directly. However, even a small amount of 
functional NDRG1 significantly decreases the severity of demye-
lination displayed in the stretcher model (King et al., 2011). Thus, 
even if NDRG1 phosphorylation is necessary for its function, the 
residual p-NDRG1 in the Sgk1-null nerves may be sufficient for 
its role in myelin maintenance.
Spatial segregation of signaling
Our data indicate that the PI 3-K signaling pathways in the 
adaxonal and abaxonal compartments are functionally distinct 
and spatially segregated. There is a marked PI 3-K substrate 
preference in each compartment despite the potential for com-
munication between them provided by the paranodes and inci-
sures (Balice-Gordon et al., 1998). Thus, loss of Neuregulin1 
and laminin in the co-cultures and in vivo results in an asym-
metric reduction in mTOR activation and NDRG1 phosphory-
lation, respectively. Similarly, loss of 4 signaling reduces 
phosphorylation of NDRG1 but not of S6rp (Fig. 7 B).
This asymmetric phosphorylation is compartment specific, 
not ligand specific. In Schwann cells grown alone or under nonmy-
elinating co-cultures, which lack distinct cytoplasmic compart-
ments, addition of either laminin or soluble Neuregulin1 results in 
phosphorylation of both NDRG1 and S6rp (Fig. S3). In contrast, 
after myelination, despite the broad expression of NDRG1, its 
phosphorylation is restricted to the abaxonal compartment and 
outer portions of the clefts (Fig. 5, A and B). These latter results in-
dicate that signaling from integrins is confined to the abaxon, and 
to the Cajal bands in particular. Whether other key signaling path-
ways are also localized to specific compartments, as seems likely 
(Terada et al., 2013), will be of interest for further investigation.
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sodium borohydride in 0.1 M PB for 30 min and then rinsed again in 0.1 M 
PB. The cultures were then dislodged from the coverslips with forceps and 
transferred to microfuge tubes containing 0.1 M PB. The samples were 
spun for 15 min in a microfuge to pellet the cultures and then embedded in 
LR White (The London Resin Co., Ltd.). To prepare samples for embedding, 
they were dehydrated by two 10-min incubations in 50, 60, 70, and 80% 
ethanol. The pellets were then incubated in two 1-h changes of a 1:1 mix-
ture of 80% ethanol and LR White, four 30-min incubations with pure 
LR White, and an overnight incubation at 4°C in pure LR White. The next 
day the pellets were placed in gelatin capsules filled with fresh LR White 
and incubated in a 50°C oven for 2 d to polymerize the resin.
Ultrathin sections (70 nm) were placed on 400-mesh nickel grids. 
For post-embedding labeling the grids were subjected to five 2-min washes 
in PBSg (PBS containing 0.01 M glycine) and blocked for 10 min in PBSg 
containing 1% gelatin. After five 1-min washes in PBSg the grids were 
floated, section down, on 20-µl drops of primary antibodies diluted in 
PBSg/0.5% BSA or of diluent alone for controls without primary antibody 
in a moist chamber at 37°C for 3 h. The grids were then washed six times, 
2 min each in PBSg, and incubated on 20-µl drops of 10-nm gold–conjugated 
goat anti–rabbit IgG (Electron Microscopy Sciences) in a moist chamber at 
RT for 45 min. Unbound secondary antibody was removed by six 2-min 
washes in PBSg and four 1-min washes in PBS. The grids were post-fixed in 
2% glutaraldehyde/PBS for 15 min. After washing in PBS and then water, 
the grids were counterstained with uranyl acetate and lead citrate, washed, 
air dried, and analyzed on an electron microscope (model CM10; Philips).
Quantification was performed in a blind fashion by recording the 
number of immunogold particles in the adaxon, abaxon, and compact my-
elin and dividing by the number of total particles. From these values, we sub-
tracted the ratios we obtained for each compartment in the “no primary” 
control as a background correction. G-ratios were measured blindly using 
the proprietary NIS-Elements AR 3.1 image acquisition software (Nikon).
Western blotting
Cultures were lysed with PBS containing 1% SDS, 95 mM NaCl, and 10 mM 
EDTA supplemented with protease and phosphatase inhibitors (Roche). 
Neonatal sciatic nerve lysates were prepared by flash-freezing with nitro-
gen, grinding the frozen tissue in the tube with a small pestle in a 75-µl vol-
ume, and sonicating briefly. Adult sciatic nerve was also flash-frozen in 
nitrogen and macerated in a conventional ceramic mortar and pestle be-
fore sonication. All lysates were heated for 3–5 min at 95°C and centri-
fuged before protein quantification by the BCA method (Thermo Fisher 
Scientific). Lysates (10–60 µg) were boiled in sample buffer (50 mM Tris-
Cl, pH 6.8, 5% vol/vol -mercaptoethanol, 2% [wt/vol] sodium dodecyl 
sulfate, 0.1% [wt/vol] bromophenol blue, and 10% [vol/vol] glycerol) be-
fore loading into a freshly cast polyacrylamide reducing gel and run with 
an infrared pre-stained ladder (LI-COR Biosciences). Gels were transferred 
to nitrocellulose membrane and blocked (5% nonfat dry milk in Tris-buffered 
saline) before primary antibody incubation overnight at 4°C (in 5% BSA in 
Tris-buffered saline and Tween 20). After three washing steps in Tris-buffered 
saline and Tween 20 (TBST), infrared-compatible secondary antibodies 
were applied for 90 min in 5% nonfat dry milk in TBST. After a final three 
washing steps in TBST, membranes were imaged and quantified using an 
Odyssey machine (LI-COR Biosciences).
Antibodies
Primary rabbit antibodies included: monoclonal and polyclonal Akt phospho- 
substrate antibody (1:1,000 for blotting, 1:400 for staining; #9611 
and #9614; Cell Signaling Technology); MBP (1:50 for immuno-EM; 
#AB980; EMD Millipore); NDRG1 p-Ser330 (1:350 for immunofluores-
cence and immuno-EM, 1:500 for blotting; #3506; Cell Signaling Technol-
ogy); NDRG1 p-3xThr (1:350 for co-culture immunofluorescence, 1:2,500 
for sciatic nerve immunofluorescence, 1:750 for blotting; #5482; Cell Sig-
naling Technology); total NDRG1 (1:1,000 for co-culture immunofluores-
cence, 1:3,500 for sciatic nerve immunofluorescence, 1:3,000 for blotting; 
a gift of U. Suter, ETH Zurich, Zurich, Switzerland); p-Akt Thr308 and 
Ser473 (1:75 for immunofluorescence, 1:500 for blotting; #2965 and 
#9271; Cell Signaling Technology); pan-Akt (1:1,250 for blotting; #9272; 
Cell Signaling Technology); Redd1 (1:100 blotting; Abcam); PTEN (1:750 
blotting; #9559; Cell Signaling Technology); p-S6rp Ser235/6 (1:150 
staining, 1:750 blotting, #4856; Cell Signaling Technology); total S6rp 
(1:1,200 blotting; #2217; Cell Signaling Technology); and MAG-ECD 
(1:100 for immuno-EM) was generated by our laboratory as described 
previously (Pedraza et al., 1990). Mouse monoclonal antibodies included: 
1-laminin (1:25 for immunofluorescence; clone D18; DSHB, Iowa City, Iowa); 
anti–-actin clone AC15 (1:5,000 for blotting; #A-5441; Sigma-Aldrich); 
Immunofluorescence
Cultures were washed twice in phosphate-buffered saline (PBS), fixed in 4% 
paraformaldehyde (Electron Microscopy Sciences) in PBS for 15 min at room 
temperature (RT), and quenched in 75 mM NH4Cl (Sigma-Aldrich) and 
25 mM glycine (Sigma-Aldrich) in PBS for 5 min at RT and washed once in 
PBS. Fixed cultures were extracted with methanol (Thermo Fisher Scientific) 
for 10 min at 20°C, then washed three times with blocking solution, which 
contains 5% (wt/vol) bovine serum albumin (BSA; Sigma-Aldrich), 0.25% 
(vol/vol) Tween 20 (Sigma Aldrich), and 1% (vol/vol) normal donkey serum 
(Jackson ImmunoResearch Laboratories, Inc.). Primary antibodies were di-
luted in blocking solution, centrifuged for 10 min, then applied to the cover-
slips in a 30–50 µl volume overnight at 4°C. After incubation, cultures were 
washed three times with PBS (5 min each), and then secondary antibodies 
were applied in block for 90 min at RT. Cultures were then washed twice 
with PBS, a final time in distilled water, and mounted on slides with Citifluor 
(Citifluor Ltd.) with or without Hoechst (Life Technologies).
Teased sciatic nerve fibers were prepared from mouse or rat sciatic 
nerve as noted in the text and as reported previously (Maurel et al., 2007) 
with the following modifications: for p-Akt and Necl-4 immunofluorescence, 
each slide containing teased fibers was submerged in cold acetone for 15 min 
at 20°C, washed twice with PBS, and then marked with a liquid blocker 
pen (Daido Sangyo). The nerves were blocked for 1 h at RT in 2.5% (wt/vol) 
BSA, 1.5% (vol/vol) normal donkey serum, and 0.5% (vol/vol) Triton 
X-100 (Sigma-Aldrich). Application of primary and secondary antibodies 
and coverslipping was performed as described above. For -DG immuno-
fluorescence, nerve was fixed at RT for 45 min with 4% PFA in PBS. Nerves 
were permeabilized in methanol at RT for 5 min and blocked in 1% cold-
water fish gelatin (Sigma-Aldrich) in PBS. Primary antibodies were applied 
in this blocking solution; secondary antibodies were applied in 5% (wt/vol) 
BSA, 1% (vol/vol) normal donkey serum, and 0.4% (vol/vol) Triton X-100 
(Sigma-Aldrich).
Immunofluorescence image acquisition
Immunofluorescence images were obtained by laser-scanning confocal mi-
croscopy on a microscope (LSM 510; Carl Zeiss) using a 63× oil-immersion 
objective (Carl Zeiss) or a wide-field epifluorescence microscope (Eclipse 
Ti; Nikon) using 60× and 100× oil immersion objectives at RT. All images 
were taken of fixed cultures or sciatic nerve as noted in the text using 
Fluoromount-G mounting media (SouthernBiotech).
For confocal microscopy, a series of images taken in the vertical di-
mension using Z-stacking technology was compressed into a single image 
using the 3D projection tool of LSM Image Examiner software (version 
4.0.0.421; Carl Zeiss). For wide-field imaging, we used the proprietary 
NIS-Elements AR 3.1 image acquisition software (Nikon) without deconvo-
lution. In some cases, the brightness and contrast of immunofluorescence 
and immuno-EM images were adjusted in Photoshop CS5 (Adobe Sys-
tems); panels in each figure were processed equivalently.
Electron microscopy
Mice were perfused with 4% paraformaldehyde and 2.5% glutaraldehyde 
in 0.1 M phosphate buffer and 0.1 M d-sucrose at pH 7.4. Sciatic nerves 
were dissected and post-fixed in the same solution for 36 h, fixed in a solu-
tion of 1% osmium tetroxide in 0.1 M phosphate buffer, and progressively 
dehydrated in ethanol and propylene oxide. Finally, nerves were embed-
ded in EMbed 812 (Epon 812 substitute) resin. All reagents used to pre-
pare tissues for electron microscopy were purchased from Electron 
Microscopy Sciences.
Embedded nerves were cut into 70-nm ultrathin cross sections using 
a UCT microtome (Leica) and glass knife. Sections were placed on grids 
and stained with 3% uranyl acetate (aqueous) in 50% methanol and coun-
terstained with Reynold’s lead citrate. Sections were then visualized using 
an electron microscope (model CM12; Philips). The g-ratio was calculated 
by dividing the diameter of an axon (without the surrounding sheath) by the 
diameter of the same axon including the myelin sheath. Over 500 axons 
were calculated per mouse and two mice were analyzed per genotype. All 
measurements and ultrastructural abnormalities were recorded in a blinded 
fashion. G-ratios were calculated using NIS Elements AR imaging software 
(version 3.1; Nikon).
The processing of myelinating cultures for immunoelectron micros-
copy was performed as described previously with slight modifications 
(Einheber et al., 1993). Myelinating cultures grown on collagen-coated 
glass coverslips for 2 mo were rinsed in PBS containing a phosphatase in-
hibitor cocktail (Roche) and then fixed in 3.75% acrolein and 2% parafor-
maldehyde in 0.1 M sodium phosphate buffer, pH 7.4 (0.1 M PB) for 
15 min at RT. After washing in 0.1 M PB the cultures were incubated in 0.5% 
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loxP site into intron 1 and two others in intron 6 flanking a NEO cassette 
(which was flanked by FRT sites) and mated with the global Cre-deleter 
line BALB/c-Tg(CMV-cre)1Gcn/J from The Jackson Laboratory (Fejes-Tóth 
et al., 2008). The other Sgk1-null line was generated using a similar ap-
proach in which a loxP site was introduced into intron 3 and two others 
flanking a NEO casette in intron 11; the resulting homologously recom-
bined ES cell clones were then transiently transfected with Cre recombi-
nase (Wulff et al., 2002). The Sgk3-null animal was generated by replacing 
parts of exons 10 and 11 as well as the intron between them with an in-
frame STOP codon (McCormick et al., 2004). The 4 integrin–signaling 
mutant was generated by replacing the signaling moiety of the cytoplas-
mic domain of 4 C-terminal to Thr1355 with a stop codon, a SV40 
polyadenylation signal, and a NEO cassette (Nikolopoulos et al., 2004). 
The stretcher mouse is a spontaneous deletion of exons 10–14 of the 
Ndrg1 gene (King et al., 2011). The Neuregulin1 type III CRD-null mouse 
was generated by homologous recombination of a nonsense mutation 
and an antisense NEO cassette into the cysteine-rich domain region of 
the Neuregulin1 gene (Wolpowitz et al., 2000). All three Akt isoform-
specific mice were obtained from The Jackson Laboratory.
Statistical methods
All one-way ANOVA and two-tailed Student’s t tests performed were com-
puted using Excel 2007 (Microsoft) or Prism (GraphPad Software).
Online supplemental material
Fig. S1 demonstrates the subcellular localization of NDRG1 and phospho-
substrates. Fig. S1 A shows that total and phospho-specific NDRG1 anti-
bodies stained wild type but not stretcher co-cultures, indicating they are 
specific. Fig. S1 B shows that staining of stretcher cultures with the 
p-Sub–staining antibody was reduced, notably in the abaxon, but was not 
abolished. Fig. S1 C demonstrates that p-Akt localizes to the paranodes, 
identified by expression of Caspr, as myelin sheaths mature; p-Akt is sim-
ilarly localized to the paranodes of neonatal sciatic nerves. Fig. S2 A 
shows ultrastructural localization of p-NDRG1, myelin-associated glyco-
protein, and MBP by immunoelectron microscopy of myelinating co-cultures, 
quantified in Fig. S2 B; these results support an abaxonal localization 
of p-NDRG1 (S330). Fig. S2 C demonstrates that S6rp phosphorylation 
is dependent on Neuregulin1 type III expression in the co-cultures. Fig. S3 
shows that adding Matrigel to pure Schwann cell cultures does not in-
crease phosphorylation of NDRG1 (A), whereas adding Matrigel or 
laminin up-regulates phosphorylation of NDRG1 when Schwann cells 
are co-cultured with neurons (B), suggesting the laminin receptor is ex-
pressed in an axon-dependent manner; phosphorylation is blocked by 
the LY inhibitor. Fig. S3 C shows that soluble Neuregulin1 type III also 
increases NDRG1 phosphorylation in nonmyelinating cultures, which 
lack distinct cytoplasmic compartments. Fig. S4 A demonstrates how 
laminin receptors, particularly 4 integrin, are necessary for phosphory-
lation of NDRG1 but not S6rp. Fig. S4, C and D show that kinases that 
phosphorylated NDRG1 include Akt1 and Sgk1 at P10 and Sgk1 and 
Sgk3 in the adult nerve. Fig. S5 A demonstrates that loss of 4 integrin 
signaling causes modest hypermyelination. Fig. S5 B shows that hyper-
myelination in the Sgk1 nulls is unlikely to be the result of known nega-
tive regulators of myelination such as DLG1 and REDD1; thus, whereas 
REDD1 levels were modestly reduced, mTOR activity (indicated by p-S6rp 
levels), its negatively regulated effector, was not consistently increased. 
Online supplemental material is available at http://www.jcb.org/cgi/ 
content/full/jcb.201307057/DC1.
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-dystroglycan antibody clone IIH6 (1:400 for staining; a gift of 
K. Campbell, University of Iowa, Iowa City, IA; Ervasti and Campbell, 1993); 
and Dlg1/Sap97 clone K64/15 (1:250 for blotting; Neuromab, Univer-
sity of California, Davis, Davis, CA). Guinea pig antibodies included: 
Caspr1 (1:3,000 for immunofluorescence; a gift of M. Bhat, University of 
Texas Health Science Center, San Antonio, TX); Necl-4 generated in our 
laboratory and used for staining as described previously (Maurel et al., 
2007); Oct6/POU3F1 (1:16,000 for immunofluorescence; a gift from 
J. Dasen, NYU School of Medicine, New York, NY). Other antibodies were 
chicken anti-MBP (1:50 for immunofluorescence and 1:750 for blotting; 
#AB9348; EMD Millipore), chicken anti-P0 (1:50 for immunofluorescence 
and 1:1,000 for blotting; #AB9352; EMD Millipore); sheep anti-Mupp1 
(1:100 for immunofluorescence; from O. Peles, Weizmann Institute, Re-
hovot, Israel).
Secondary antibodies used for immunofluorescence were from Jackson 
ImmunoResearch Laboratories, Inc., and raised in donkey and conjugated 
to either rhodamine, Alexa Fluor 488, Cy5, Dylight649, or AMCA. Sec-
ondary antibodies for Western blotting were from LI-COR Biosciences, 
raised in goat, and conjugated to IRDye800 or IRDye680 for dual-color in-
frared detection.
Schwann cell induction and inhibition
Pure Schwann cells and Schwann cell–neuron co-cultures maintained 
in nonmyelinating media for 10–14 d were briefly washed three times in 
warmed starvation media (MEM and 10 µM l-glutamine). Cultures were in-
cubated in starvation media for 5–6 h in the presence or absence of 20 µM 
LY294002 (LC Labs). Aliquots of 10 µg/ml natural mouse laminin (Life 
Technologies) or 1 mg/ml Matrigel (BD) were diluted freshly in the pres-
ence or absence of 20 µM LY294002 in the same media. At the end of the 
incubation, pre-warmed preparations of diluted natural mouse laminin or 
Matrigel were applied to the cultures for 30 min. Cells were then placed 
on ice and rinsed with pre-chilled PBS before lysis.
Non-myelinating co-cultures of Schwann cells and sensory neurons 
were maintained in serum-containing media for 48 h before an 18-h appli-
cation of 20 µM LY294004 (LC Labs), 25 nM rapamycin (LC Labs), or 
40 µM PF4708671 (Sigma-Aldrich) in defined, serum-free media.
Reverse-transcription PCR
Isolation of mRNA from pure cultures of rat sensory neurons or Schwann 
cells was performed with TRIzol reagent (Life Technologies) according 
to the manufacturer’s instructions. The mRNA was resuspended in Am-
bion RNA storage solution (Life Technologies) and quantified using a 
spectrophotometer (model DU-800; Beckman Coulter). 1 µg of mRNA 
was used to make 20 µl of cDNA using an RNase Easy kit (QIAGEN). 
For each PCR reaction performed with the Fermentas DreamTaq mas-
ter mix (Thermo Fisher Scientific), 1 µl of cDNA was used. The PCR 
program for all primers involved 30 cycles of denaturation at 95°C, 
annealing at 60°C, and extension at 72°C followed by an additional 
final extension step before holding at 4°C. Primers were designed 
using the NCBI Blast tool to confirm specificity and standardize prod-
uct size to 100 bp. The GAPDH primer pair spans an intron–exon 
junction. The primer sequences are listed in the 5 to 3 direction as 
follows: GAPDH fwd, ACAAGATGGTGAAGGTCGGTGTGA; GAPDH 
rev, AGCTTCCCATTCTCAGCCTTGACT; Sgk1 fwd, GCTCCCAGGATG-
GTTCCGAAGGA; Sgk1 rev, TCCGGAAAGCTTCCGCGTCA; Sgk2 fwd, 
AGTCAGGCGAGTGGGTGACAGG; Sgk2 rev, TGGAAACCCCCAG-
GTTCCAGC; and Sgk3 fwd, TCGCTATTTCTGATACCACCACAACC; 
Sgk3 rev, AGGCTCACTCCTGGTCTCAAGTTCA.
Mouse models
All of the mouse models used in this project have been described previ-
ously. The 2-laminin knockout was generated by knocking a pMC1neo 
polyA+ cassette (Agilent Technologies) into an exon (aa 128–209) as 
described previously (Nakagawa et al., 2001). The 1 integrin condi-
tional allele was generated by targeting two loxP sites to both sides of the 
first coding exon of the gene (Graus-Porta et al., 2001; Feltri et al., 
2002). The 4 integrin conditional allele (Nodari et al., 2008) was gen-
erated using the m4intc targeting vector, which contains the first 7 in-
trons and exons of 4 genomic DNA and the necessary loxP sites 
(Dowling et al., 1996). The dystroglycan conditional allele was gener-
ated by inserting a floxed NEO cassette into the exon 2 locus (Moore 
et al., 2002). The P0-CRE line was generated by cloning in recombinant 
CRE downstream of the full-length 6-kb promoter of the mouse P0 gene 
(Feltri et al., 1999). Two Sgk1-null lines in the same C57/Sv129 mixed 
background were used in this study. The first was generated by cloning a 
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